Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Boletín médico del Hospital Infantil de México
versión impresa ISSN 1665-1146
Resumen
HERRERA-SILVA, Jorge Carlos; TREVINO-MOORE, Aída y LOPEZ-BELTRAN, Ana Laura. Metabolic syndrome in cancer patients under chemotherapy treatment. Bol. Med. Hosp. Infant. Mex. [online]. 2008, vol.65, n.2, pp.110-120. ISSN 1665-1146.
Introduction. Metabolic syndrome is one of the main health problem worldwide including cancer patients. Objectives. To know and to compare the prevalence of the metabolic syndrome in children with different neoplasms over chemotherapy treatment. Methods. Through prospective, longitudinal, comparative and analytical study, anthropometric, clinical and blood measurements were carried out in a group of pediatrics patients with cancer. Results. Fifty-eight patients participated. The global prevalence of the syndrome was 32.75 at the beginning, and 79.31% at the end. The 3 measurements were different for syndrome indicators as well as the number of positive patients (P <0.05). Blood pressure, height and weight were moderately associated with waist and hip perimeters. Conclusions. The metabolic syndrome prevalence in pediatric cancer patients is very high, with no difference due to cancer type.
Palabras llave : Metabolic syndrome; cancer; prevalence; chemotherapy.